Janus Henderson Group PLC Neogenomics Inc Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,000,560 shares of NEO stock, worth $12.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000,560
Previous 5,741,026
65.15%
Holding current value
$12.2 Million
Previous $54.5 Million
73.16%
% of portfolio
0.01%
Previous 0.03%
Shares
33 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
129MCall Options Held
1.1MPut Options Held
296K-
Black Rock Inc. New York, NY19.7MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$85.9 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$45.2 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$41.6 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$31.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $765M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...